As of 2025-12-23, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 16.1x | 15.4x |
| Forward P/E multiples | 20.9x - 42.8x | 30.9x |
| Fair Price | (95.50) - (74.90) | (105.36) |
| Upside | -239.4% - -209.4% | -253.8% |
| Date | EV/EBITDA |